NuGen Medical Devices Inc. NGMD.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 85.17% | -208.55% | -1,122.88% | 37.52% | -142.06% |
| Total Depreciation and Amortization | -180.07% | 10.56% | 26.99% | 7.98% | 1.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -143.24% | 119.11% | 409.24% | -18.00% | 384.37% |
| Change in Net Operating Assets | -188.07% | 110.50% | 96.84% | -106.52% | -69.99% |
| Cash from Operations | -61.30% | -28.69% | 64.68% | -16.84% | -227.30% |
| Capital Expenditure | -- | -- | -1,586.49% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -331.85% | -- | 33.33% | -166.67% | -12,666.67% |
| Cash from Investing | 228.98% | -- | -1,523.38% | -18,400.00% | -12,666.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -100.00% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.19% | -87.26% | 51.57% | -112.21% | -239.95% |